Fattahi Abdizadeh, M and Latifnia, M (2020) SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial. Clinical infectious diseases.
Full text not available from this repository.Item Type: | Article |
---|---|
Subjects: | R Medicine > R Medicine (General) |
Depositing User: | Saeed Shoja |
Date Deposited: | 23 Aug 2020 07:53 |
Last Modified: | 23 Aug 2020 07:53 |
URI: | http://eprints.medsab.ac.ir/id/eprint/1623 |
Actions (login required)
View Item |